Results 11 to 20 of about 9,652,955 (180)

Pre-Exposure Prophylaxis Barriers, Facilitators and Unmet Need Among Rural People Who Inject Drugs: A Qualitative Examination of Syringe Service Program Client Perspectives [PDF]

Frontiers in Psychiatry, 2022
BackgroundPeople who inject drugs (PWID) are at high risk for HIV infection, yet in rural areas PWID are understudied with respect to prevention strategies.
Hilary L. Surratt, Hilary L. Surratt, Hannah J. Yeager, Akosua Adu, Evelyn A. González, Elizabeth O. Nelson, Tamara Walker   +6 more
doaj   +2 more sources

Syringe service program utilization, behavioral, and experiential factors associated with greater naloxone protection in a longitudinal cohort of people who use illicit opioids in New York city [PDF]

Harm Reduction Journal
Background Despite efforts to blanket high-mortality communities with no-cost naloxone, drug checking technologies, and alternatives to using opioids alone, there remains a considerable lack of knowledge about how exposure to these low-threshold ...
Alex S. Bennett, Yuyu Chen, Adrian Harris, David Frank, Saba Rouhani, Alice Cepeda, Alverado Valdez, Jemar R. Bather, Melody S. Goodman, Luther Elliott   +9 more
doaj   +2 more sources

Gender differences regarding interest in opioid agonist treatment with hydromorphone: a cross-sectional study of syringe service program participants [PDF]

Harm Reduction Journal
Background In the United States, only 15–20% of people with opioid use disorder (OUD) receive medications for OUD annually. Injectable opioid agonist treatment with hydromorphone (iOAT-H) is a novel approach that reduces non-prescribed opioid use ...
Vitaliy Lasiychuk, Megan Ghiroli, Teresa López-Castro, Aaron D. Fox   +3 more
doaj   +2 more sources

Facilitators and barriers to monitoring and evaluation at syringe service programs

Harm Reduction Journal
Background Syringe services programs (SSPs) provide harm reduction supplies and services to people who use drugs and are often required by funders or partners to collect data from program participants.
Elise Healy, Arianna Rubin Means, Kelly Knudtson, Noah Frank, Alexa Juarez, Stephanie Prohaska, Courtney McKnight, Don Des Jarlais, Alice Asher, Sara N. Glick   +9 more
doaj   +3 more sources

Association between a citywide ban on syringe distribution and provision of harm reduction services [PDF]

Drug and Alcohol Dependence Reports
Background: Syringe services programs (SSPs) decrease HIV and overdose incidence among people who use drugs (PWUD). In May 2024, Pueblo, Colorado, banned syringe distribution, citing public complaints about syringe litter.
Pranav Padmanabhan, Paul Christine, Jarratt Pytell, Nikki Wagner, Jason Gibbons, Christine Charron, Katherine LeMasters   +6 more
doaj   +2 more sources

Reduced injection risk behavior with co-located hepatitis C treatment at a syringe service program: The accessible care model. [PDF]

PLoS ONE
BackgroundThe main mode of transmission of Hepatitis C in North America is through injection drug use. Availability of accessible care for people who inject drugs is crucial for achieving hepatitis C elimination.ObjectiveThe objective of this analysis is
Claire So Jeong Lee, Pedro Mateu-Gelabert, Yesenia Aponte Melendez, Chunki Fong, Shashi N Kapadia, Melinda Smith, Kristen M Marks, Benjamin Eckhardt   +7 more
doaj   +2 more sources

Healthcare utilisation and disclosure of injecting drug use among clients of Australia's needle and syringe programs

Australian and New Zealand Journal of Public Health, 2013
Background : People who inject drugs (PWID) report limited access to healthcare, and may avoid disclosing drug use. Health service utilisation was examined among participants in the Australian Needle and Syringe Program Survey (ANSPS), an annual cross ...
M. Mofizul Islam, Libby Topp, Jenny Iversen, Carolyn Day, Katherine M. Conigrave, Lisa Maher   +5 more
doaj   +2 more sources

Does perceived stigma impact opioid use disorder treatment uptake? A cross-sectional secondary analysis of buprenorphine engagement among syringe service program participants [PDF]

Addiction Science & Clinical Practice
Introduction Buprenorphine is an effective medication for opioid use disorder (OUD) treatment; however, stigma surrounding substance use may deter individuals from seeking treatment and contribute to lower engagement once treatment is initiated.
Bailey Campbell, Lindsey R. Riback, Juan Gatica Portillo, Stephanie Maricic, Aaron D. Fox   +4 more
doaj   +2 more sources

Pain is associated with reduced adherence to safer injection practices among people who inject opioids [PDF]

Harm Reduction Journal
Background Injection opioid use is associated with fatal and non-fatal harms including accidental overdose and infectious diseases. Syringe service programs offer sterile injection equipment and safer injection training to reduce the incidence of ...
O. Trent Hall, John A. Sturgeon, Jasmin Bradley, Abigail Helm, Johnathan Rausch, Emma Kuloszewski, Megan Deaner, Carlos Malvestutto, Ashley Lipps, Afton Hassett   +9 more
doaj   +2 more sources

Case Report: Reintroduction of winged infusion sets to needle syringe programs - advancing equity in harm reduction [PDF]

Frontiers in Psychiatry
BackgroundIn January 2023, following a 20-year ban, the New South Wales (NSW) Needle and Syringe Program (NSP) Guidelines permitted NSPs to provide winged infusion sets (‘butterflies’) and larger-volume syringes (‘barrels’) commonly used for injecting ...
Caroline James, Vendula Belackova, Vendula Belackova, Wendy Machin, Olivia Thackeray, Louisa Jansen, Danielle Resiak, Nina Hutchinson, Ian Anderson, Nicholas Rich, Phillip Read, Phillip Read   +11 more
doaj   +2 more sources